Practice question
Answer the question and get instant feedback.
Medium"CDC clinical guidance: eCrCl ≥60 mL/min for F/TDF; ≥30 mL/min for F/TAF. Long‑acting cabotegravir has no renal restriction. Thus F/TAF or cabotegravir are appropriate. F/TDF is not with eCrCl 42. PEP is for exposures within 72 hoursCDC Clinical Guidance (2023): HIV PrEPinfectious diseases
Educational content. Not a substitute for clinical judgement or local policy.